UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017929
Receipt number R000018942
Scientific Title The elucidation of a predictor for the onset of decline of cognitive function and dementia using large-scale cohort of diabetic and obese patients
Date of disclosure of the study information 2015/06/17
Last modified on 2015/06/19 12:17:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The elucidation of a predictor for the onset of decline of cognitive function and dementia using large-scale cohort of diabetic and obese patients

Acronym

JOMS/J-DOS2

Scientific Title

The elucidation of a predictor for the onset of decline of cognitive function and dementia using large-scale cohort of diabetic and obese patients

Scientific Title:Acronym

JOMS/J-DOS2

Region

Japan


Condition

Condition

1. Type 2 Diabetes
2. Obesity

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This aim of this study is to examine the association of the decline of cognitive functional and dementia in Japanese patients with diabetes and obesity and to elucidate effective indicators.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

MMSE (Mini-Mental State Examination)

Key secondary outcomes

FAB (Frontal Assessment Battery), Brain MRI


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Type 2 diabetes and/or Obesity.
2) Lower age limit: 20 years old
3) Gender: male and female.
4) Outpatients and/or inpatients seeking treatment for lifestyle disease diseases in the hospitals of National Hospital Organization.
5) Patients who have provided written informed consent.

Key exclusion criteria

1) Secondary obesity associated with endocrine disorders.
2) Severe liver dysfunction and liver cirrhosis.
3) Severe renal dysfunction (serum creatinine >= 3.0mg/dl).
4) Patients who are pregnant or under preconceptional care.
5) Subjects judged by the investigator/project leader to be ineligible for other reasons.

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriko Asahara

Organization

National Hospital Organization Kyoto Medical Center

Division name

Division of Diabetic Research, Clinical Research Institute

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto

TEL

075-641-9161

Email

nsato@kyotolan.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Noriko Asahara

Organization

National Hospital Organization Kyoto Medical Center

Division name

Division of Diabetic Research, Clinical Research Institute

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto

TEL

075-641-9161

Homepage URL


Email

nsato@kyotolan.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Kyoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

H26-NHO(Diabetes)-02

Org. issuing International ID_1

National Hospital Organization

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都医療センター(京都府)、小倉医療センター(福岡県)、名古屋医療センター(愛知県)、三重病院(三重県)、長崎川棚医療センター(長崎県)、九州医療センター(福岡県)、徳島病院(徳島県)、金沢医療センター(石川県)、熊本医療センター(熊本県)、函館病院(北海道)、三重中央医療センター(三重県)、埼玉病院(埼玉県)、広島西医療センター(広島県)、西別府病院(大分県)、西群馬病院(群馬県)、千葉東病院(千葉県)


Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 01 Month 24 Day

Date of IRB


Anticipated trial start date

2015 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Main Observation Item:
1. Plasma glucose level, HbA1c, serum insulin level
2. Adipocytokine (Adiponectin, Leptin)
3. Body weight, BMI, waist circumference


Management information

Registered date

2015 Year 06 Month 16 Day

Last modified on

2015 Year 06 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018942


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name